|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang X, Liu X, Du B, Liu X, Xue M, Yan Q,
Wang X and Wang Q: lncRNA LINC01305 promotes cervical cancer
progression through KHSRP and exosome-mediated transfer. Aging
(Albany NY). 13:19230–19242. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Agarwal R and Kaye SB: Ovarian cancer:
Strategies for overcoming resistance to chemotherapy. Nat Rev
Cancer. 3:502–516. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burki TK: Cervical cancer: Screening and
risk with age. Lancet Oncol. 15:e1072014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeng H, Chen W, Zheng R, Zhang S, Ji J,
Zou X, Xia C, Sun K, Yang Z, Li H, et al: Changing cancer survival
in China during 2003–15: A pooled analysis of 17 population-based
cancer registries. Lancet Glob Health. 6:e555–e567. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong Z, Zhang S, Zhang W, Huang H, Li Q,
Deng H, Ma J, Zhou M, Xiang J, Wu M, et al: Long non-coding RNAs in
cancer. Sci China Life Sci. 55:1120–1124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hemberg M, Gray JM, Cloonan N, Kuersten S,
Grimmond S, Greenberg ME and Kreiman G: Integrated genome analysis
suggests that most conserved non-coding sequences are regulatory
factor binding sites. Nucleic Acids Res. 40:7858–7869. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang M, Wang C and Mu L: miR-148a induces
apoptosis by upregulating BIM expression in gastric cancer cells.
Int J Clin Exp Med. 10:2791–2799. 2017.
|
|
13
|
Shen J, Zhang J, Xiao M, Yang J and Zhang
N: miR-203 suppresses bladder cancer cell growth and targets
Twist1. Oncol Res. 26:1155–1165. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang L, Yang B, Cao X, Li Q, Jiang L and
Wang D: MicroRNA-377-3p inhibits growth and invasion through
sponging JAG1 in ovarian cancer. Genes Genomics. 41:919–926. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang X, Li Z, Zhang Q, Wang W, Li B, Wang
L, Xu Z, Zeng A, Zhang X, Zhang X, et al: Circular RNA AKT3
upregulates PIK3R1 to enhance cisplatin resistance in gastric
cancer via miR-198 suppression. Mol Cancer. 18:712019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu G, Wan Q, Li J, Hu X, Gu X and Xu S:
Circ_0038467 regulates lipopolysaccharide-induced inflammatory
injury in human bronchial epithelial cells through sponging
miR-338-3p. Thorac Cancer. 11:1297–1308. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bill M, Papaioannou D, Karunasiri M,
Kohlschmidt J, Pepe F, Walker CJ, Walker AE, Brannan Z,
Pathmanathan A, Zhang X, et al: Expression and functional relevance
of long non-coding RNAs in acute myeloid leukemia stem cells.
Leukemia. 33:2169–2182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Huang D, Huang J, Nie K, Li X and
Yang X: lncRNA TMPO-AS1 exerts oncogenic roles in HCC through
regulating miR-320a/SERBP1 axis. Onco Targets Ther. 13:6539–6551.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li W, Zhang B, Jia Y, Shi H, Wang H, Guo Q
and Li H: lncRNA LOXL1-AS1 regulates the tumorigenesis and
development of lung adenocarcinoma through sponging miR-423-5p and
targeting MYBL2. Cancer Med. 9:689–699. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan SY, Chen MM, Li GM, Wang YQ and Fan
JG: miR-32 induces cell proliferation, migration, and invasion in
hepatocellular carcinoma by targeting PTEN. Tumour Biol.
36:4747–4755. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sempere LF, Christensen M, Silahtaroglu A,
Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S and Cole CN:
Altered MicroRNA expression confined to specific epithelial cell
subpopulations in breast cancer. Cancer Res. 67:11612–11620. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xie H, Liao X, Chen Z, Fang Y, He A, Zhong
Y, Gao Q, Xiao H, Li J, Huang W and Liu Y: lncRNA MALAT1 inhibits
apoptosis and promotes invasion by antagonizing miR-125b in bladder
cancer cells. J Cancer. 8:3803–3811. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang X, Wang L, Xie S, Chen Y, Song S, Lu
Y and Lu D: Long noncoding RNA MEG3 blocks telomerase activity in
human liver cancer stem cells epigenetically. Stem Cell Res Ther.
11:5182020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma P, Pan Y, Yang F, Fang Y, Liu W, Zhao
C, Yu T, Xie M, Jing X, Wu X, et al: KLF5-modulated lncRNA NEAT1
contributes to tumorigenesis by acting as a scaffold for BRG1 to
silence GADD45A in gastric cancer. Mol Ther Nucleic Acids.
22:382–395. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen SN, Li K, Liu Y, Yang CL, He CY and
Wang HR: Silencing lncRNAs PVT1 upregulates miR-145 and confers
inhibitory effects on viability, invasion, and migration in EC. Mol
Ther Nucleic Acids. 19:668–682. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang W, Xu X, Hong L, Wang Q, Huang J and
Jiang L: Upregulation of lncRNA GAS5 inhibits the growth and
metastasis of cervical cancer cells. J Cell Physiol.
234:23571–23580. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yuan LY, Zhou M, Lv H, Qin X, Zhou J, Mao
X, Li X, Xu Y, Liu Y and Xing H: Involvement of NEAT1/miR-133a axis
in promoting cervical cancer progression via targeting SOX4. J Cell
Physiol. 234:18985–18993. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen F, Zheng H, Zhou L, Li W and Xu X:
Overexpression of MALAT1 contributes to cervical cancer progression
by acting as a sponge of miR-429. J Cell Physiol. 234:11219–11226.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lai SY, Guan HM, Liu J, Huang LJ, Hu XL,
Chen YH, Wu YH, Wang Y, Wu Q and Zhou JY: Long noncoding RNA SNHG12
modulated by human papillomavirus 16 E6/E7 promotes cervical cancer
progression via ERK/Slug pathway. J Cell Physiol. 235:7911–7922.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW,
Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al: Rapid identification
of UCA1 as a very sensitive and specific unique marker for human
bladder carcinoma. Clin Cancer Res. 12:4851–4858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luan Y, Li X, Luan Y, Zhao R, Li Y, Liu L,
Hao Y, Oleg Vladimir B and Jia L: Circulating lncRNA UCA1 promotes
malignancy of colorectal cancer via the miR-143/MYO6 axis. Mol Ther
Nucleic Acids. 19:790–803. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu Y, Gao F, He Q, Li G and Ding G: lncRNA
UCA1 functions as a ceRNA to promote prostate cancer progression
via sponging miR143. Mol Ther Nucleic Acids. 19:751–758. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He X, Wang J, Chen J, Han L, Lu X, Miao D,
Yin D, Geng Q and Zhang E: lncRNA UCA1 predicts a poor prognosis
and regulates cell proliferation and migration by repressing p21
and SPRY1 expression in GC. Mol Ther Nucleic Acids. 18:605–616.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li HJ, Sun XM, Li ZK, Yin QW, Pang H, Pan
JJ, Li X and Chen W: lncRNA UCA1 promotes mitochondrial function of
bladder cancer via the miR-195/ARL2 signaling pathway. Cell Physiol
Biochem. 43:2548–2561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei H, Qiu YQ, Zeng QS, Wang SF and Yi CJ:
lncRNA UCA1 regulates proliferation, migration and invasion of
cervical cancer cells by targeting miR-145. Eur Rev Med Pharmacol
Sci. 24:3555–3564. 2020.PubMed/NCBI
|
|
36
|
He Q, Meng J, Liu S, Zeng Q, Zhu Q, Wei Z
and Shao Y: Long non-coding RNA UCA1 upregulates KIF20A expression
to promote cell proliferation and invasion via sponging miR-204 in
cervical cancer. Cell Cycle. 19:2486–2495. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang TJ, Wang L, Zhang Y, Zheng JD and Liu
L: lncRNA UCA1 regulates cervical cancer survival and EMT
occurrence by targeting miR-155. Eur Rev Med Pharmacol Sci.
24:9869–9879. 2020.PubMed/NCBI
|
|
38
|
Zhang Y, Pan Q and Shao Z:
Tumor-suppressive role of microRNA-202-3p in hepatocellular
carcinoma through the KDM3A/HOXA1/MEIS3 pathway. Front Cell Dev
Biol. 8:5560042021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang Y and Qin H: miR-338-3p targets RAB23
and suppresses tumorigenicity of prostate cancer cells. Am J Cancer
Res. 8:2564–2574. 2018.PubMed/NCBI
|
|
40
|
Wang R, Zuo X, Wang K, Han Q, Zuo J, Ni H,
Liu W, Bao H, Tu Y and Xie P: MicroRNA-485-5p attenuates cell
proliferation in glioma by directly targeting paired box 3. Am J
Cancer Res. 8:2507–2517. 2018.PubMed/NCBI
|
|
41
|
Dang S, Zhou J, Wang Z, Wang K, Dai S and
He S: miR-299-3p functions as a tumor suppressor via targeting
Sirtuin 5 in hepatocellular carcinoma. Biomed Pharmacother.
106:966–975. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen X, Qi M, Yang Q and Li J: miR-299-3p
functions as a tumor suppressor in thyroid cancer by regulating
SHOC2. Eur Rev Med Pharmacol Sci. 23:232–240. 2019.PubMed/NCBI
|
|
43
|
Wang JY, Jiang JB, Li Y, Wang YL and Dai
Y: MicroRNA-299-3p suppresses proliferation and invasion by
targeting VEGFA in human colon carcinoma. Biomed Pharmacother.
93:1047–1054. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu Y, Zhao JD and Yang H: miR-299-3p
inhibits proliferation and invasion of cervical cancer cell via
targeting TCF4. Eur Rev Med Pharmacol Sci. 23:5621–5627.
2019.PubMed/NCBI
|
|
45
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Das T, Deb A, Parida S, Mondal S, Khatua S
and Ghosh Z: LncRBase V.2: An updated resource for multispecies
lncRNAs and ClinicLSNP hosting genetic variants in lncRNAs for
cancer patients. RNA Biol. 18:1136–1151. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Waggoner SE: Cervical cancer. Lancet.
361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Roik E, Sharashova E, Kharkova O, Nieboer
E, Postoev V and Odland JØ: Sociodemographic characteristics,
sexual behaviour and knowledge about cervical cancer prevention as
risk factors for high-risk human papillomavirus infection in
Arkhangelsk, North-West Russia. Int J Circumpolar Health.
77:14986812018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Q, Yan SP, Chu DX, Xie Y, Wang CF,
Zhang JY, Li WC and Guo RX: Silencing of long non-coding RNA
RP1-93H18.6 acts as a tumor suppressor in cervical cancer through
the blockade of the PI3K/Akt axis. Mol Ther Nucleic Acids.
19:304–317. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen DZ, Wang TF, Dai WC, Xu X and Chen
PF: lncRNA FOXD2-AS1 accelerates the progression of cervical cancer
via downregulating CDX1. Eur Rev Med Pharmacol Sci. 23:10234–10240.
2019.PubMed/NCBI
|
|
52
|
Zhang Q, Zheng J and Liu L: The long
noncoding RNA PCGEM1 promotes cell proliferation, migration and
invasion via targeting the miR-182/FBXW11 axis in cervical cancer.
Cancer Cell Int. 19:3042019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Guo Z, Wang X, Yang Y, Chen W, Zhang K,
Teng B, Huang C, Zhao Q and Liu Z: Hypoxic tumor-derived exosomal
long noncoding RNA UCA1 promotes angiogenesis via miR-96-5p/AMOTL2
in pancreatic cancer. Mol Ther Nucleic Acids. 22:179–195. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Cao Y, Xiong JB, Zhang GY, Liu Y, Jie ZG
and Li ZR: Long noncoding RNA UCA1 regulates PRL-3 expression by
sponging microRNA-495 to promote the progression of gastric cancer.
Mol Ther Nucleic Acids. 19:853–864. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhao J, Li L and Yang T: miR-216a-3p
suppresses the proliferation and invasion of cervical cancer
through downregulation of ACTL6A-mediated YAP signaling. J Cell
Physiol. 235:9718–9728. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Pan SS, Zhou HE, Yu HY and Xu LH:
miR-195-5p inhibits the cell migration and invasion of cervical
carcinoma through suppressing ARL2. Eur Rev Med Pharmacol Sci.
23:10664–10671. 2019.PubMed/NCBI
|
|
57
|
Ji X, Guo H, Yin S and Du H: miR-139-5p
functions as a tumor suppressor in cervical cancer by targeting
TCF4 and inhibiting Wnt/β-catenin signaling. Onco Targets Ther.
12:7739–7748. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang D and Hu Y: Long non-coding RNA PVT1
competitively binds microRNA-424-5p to regulate CARM1 in
radiosensitivity of non-small-cell lung cancer. Mol Ther Nucleic
Acids. 16:130–140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang G, He X, Ren C, Lin J and Wang Q:
Long noncoding RNA PCA3 regulates prostate cancer through sponging
miR-218-5p and modulating high mobility group box 1. J Cell
Physiol. 234:13097–13109. 2019. View Article : Google Scholar : PubMed/NCBI
|
